INBIOGEN Co., Ltd. (KRX:101140)

INBIOGEN Revenue

INBIOGEN had revenue of 786.28M KRW in the quarter ending March 31, 2026, a decrease of -52.04%. This brings the company's revenue in the last twelve months to 5.44B, down -25.55% year-over-year. In the year 2025, INBIOGEN had annual revenue of 6.30B, down -10.57%.

• Revenue (ttm): 5.44B
• Revenue Growth: -25.55%
• P/S Ratio: 13.81
• Revenue / Employee: 132.77M
• Employees: 41
• Market Cap: 75.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.30B	-744.31M	-10.57%
Dec 31, 2024	7.04B	800.26M	12.82%
Dec 31, 2023	6.24B	-4.18B	-40.10%
Dec 31, 2022	10.42B	-61.30M	-0.58%
Dec 31, 2021	10.48B	263.11M	2.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error